Brown Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.98M | Sell |
3,780
-489
| -11% | -$257K | ﹤0.01% | 661 |
|
2025
Q1 | $2.71M | Sell |
4,269
-247
| -5% | -$157K | ﹤0.01% | 595 |
|
2024
Q4 | $3.22M | Sell |
4,516
-109
| -2% | -$77.6K | ﹤0.01% | 569 |
|
2024
Q3 | $4.86M | Sell |
4,625
-37
| -0.8% | -$38.9K | 0.01% | 511 |
|
2024
Q2 | $4.9M | Buy |
4,662
+13
| +0.3% | +$13.7K | 0.01% | 501 |
|
2024
Q1 | $4.47M | Buy |
4,649
+639
| +16% | +$615K | 0.01% | 509 |
|
2023
Q4 | $3.52M | Sell |
4,010
-69
| -2% | -$60.6K | 0.01% | 536 |
|
2023
Q3 | $3.36M | Sell |
4,079
-1
| -0% | -$823 | 0.01% | 529 |
|
2023
Q2 | $2.93M | Sell |
4,080
-233
| -5% | -$167K | ﹤0.01% | 545 |
|
2023
Q1 | $3.54M | Sell |
4,313
-251
| -5% | -$206K | 0.01% | 519 |
|
2022
Q4 | $3.29M | Sell |
4,564
-73
| -2% | -$52.7K | 0.01% | 533 |
|
2022
Q3 | $3.2M | Buy |
4,637
+1,675
| +57% | +$1.15M | 0.01% | 508 |
|
2022
Q2 | $1.75M | Buy |
2,962
+383
| +15% | +$226K | ﹤0.01% | 590 |
|
2022
Q1 | $1.8M | Sell |
2,579
-26
| -1% | -$18.2K | ﹤0.01% | 600 |
|
2021
Q4 | $1.65M | Buy |
2,605
+198
| +8% | +$125K | ﹤0.01% | 631 |
|
2021
Q3 | $1.46M | Buy |
2,407
+3
| +0.1% | +$1.82K | ﹤0.01% | 630 |
|
2021
Q2 | $1.34M | Buy |
2,404
+114
| +5% | +$63.7K | ﹤0.01% | 639 |
|
2021
Q1 | $1.08M | Buy |
2,290
+9
| +0.4% | +$4.26K | ﹤0.01% | 687 |
|
2020
Q4 | $1.1M | Sell |
2,281
-450
| -16% | -$217K | ﹤0.01% | 634 |
|
2020
Q3 | $1.53M | Buy |
2,731
+4
| +0.1% | +$2.24K | ﹤0.01% | 544 |
|
2020
Q2 | $1.7M | Buy |
2,727
+34
| +1% | +$21.2K | ﹤0.01% | 523 |
|
2020
Q1 | $1.31M | Buy |
2,693
+20
| +0.7% | +$9.76K | ﹤0.01% | 529 |
|
2019
Q4 | $1M | Buy |
2,673
+127
| +5% | +$47.7K | ﹤0.01% | 634 |
|
2019
Q3 | $707K | Buy |
2,546
+1,246
| +96% | +$346K | ﹤0.01% | 683 |
|
2019
Q2 | $407K | Sell |
1,300
-790
| -38% | -$247K | ﹤0.01% | 803 |
|
2019
Q1 | $859K | Buy |
2,090
+168
| +9% | +$69K | ﹤0.01% | 837 |
|
2018
Q4 | $717K | Sell |
1,922
-1,238
| -39% | -$462K | ﹤0.01% | 835 |
|
2018
Q3 | $1.28M | Sell |
3,160
-8,663
| -73% | -$3.5M | ﹤0.01% | 747 |
|
2018
Q2 | $4.08M | Buy |
11,823
+8,898
| +304% | +$3.07M | 0.01% | 479 |
|
2018
Q1 | $1.01M | Buy |
2,925
+90
| +3% | +$31K | ﹤0.01% | 648 |
|
2017
Q4 | $1.07M | Buy |
2,835
+110
| +4% | +$41.3K | ﹤0.01% | 658 |
|
2017
Q3 | $1.22M | Sell |
2,725
-21
| -0.8% | -$9.39K | ﹤0.01% | 617 |
|
2017
Q2 | $1.35M | Sell |
2,746
-146
| -5% | -$71.7K | ﹤0.01% | 611 |
|
2017
Q1 | $1.12M | Buy |
2,892
+252
| +10% | +$97.7K | ﹤0.01% | 617 |
|
2016
Q4 | $969K | Buy |
2,640
+678
| +35% | +$249K | ﹤0.01% | 638 |
|
2016
Q3 | $788K | Sell |
1,962
-1,540
| -44% | -$619K | ﹤0.01% | 660 |
|
2016
Q2 | $1.22M | Buy |
3,502
+1,651
| +89% | +$577K | ﹤0.01% | 566 |
|
2016
Q1 | $667K | Sell |
1,851
-69
| -4% | -$24.9K | ﹤0.01% | 653 |
|
2015
Q4 | $1.04M | Buy |
1,920
+58
| +3% | +$31.5K | ﹤0.01% | 564 |
|
2015
Q3 | $866K | Buy |
1,862
+1,132
| +155% | +$526K | ﹤0.01% | 588 |
|
2015
Q2 | $372K | Sell |
730
-1,340
| -65% | -$683K | ﹤0.01% | 694 |
|
2015
Q1 | $935K | Sell |
2,070
-169
| -8% | -$76.3K | ﹤0.01% | 564 |
|
2014
Q4 | $919K | Sell |
2,239
-799
| -26% | -$328K | ﹤0.01% | 569 |
|
2014
Q3 | $1.1M | Buy |
3,038
+104
| +4% | +$37.5K | ﹤0.01% | 532 |
|
2014
Q2 | $830K | Buy |
2,934
+35
| +1% | +$9.9K | ﹤0.01% | 587 |
|
2014
Q1 | $871K | Buy |
2,899
+16
| +0.6% | +$4.81K | ﹤0.01% | 556 |
|
2013
Q4 | $794K | Buy |
2,883
+350
| +14% | +$96.4K | ﹤0.01% | 554 |
|
2013
Q3 | $793K | Buy |
+2,533
| New | +$793K | ﹤0.01% | 543 |
|